Partial ileal bypass is effective in reducing circulating cholesterol levels. In our study the 10 year effects of the procedure on serum lipids and lipoproteins were studied in 27 patients with heterozygous familial hypercholesterolemia. The ileal bypass patients were compared with conservatively treated case controls matched for age, sex, serum cholesterol level, relative body weight, blood pressure, and smoking habits and also for the existence of diabetes and coronary heart disease. Serum triglycerides were initially slightly higher in the patients undergoing ileal bypass. During the 10 year follow-up eight surgically treated and seven control patients suffered fatal or nonfatal myocardial infarctions. Of these all but one male subject who underwent surgery had had manifest coronary heart disease at entry. Male sex, smoking, triglyceride levels, and angina were significant predictors of new coronary events. The fall in serum cholesterol in patients who underwent ileal bypass and had fatal myocardial infarctions was smaller than in the corresponding subjects without events. The serum lipid levels of the survivors at the end of the 10 year follow-up showed that ileal bypass, as compared with the conservative treatment, had led to a larger decrease in total serum cholesterol ( -33% vs -1 1 % in the control patients; p < .001); lower total serum cholesterol (360 vs 468 mg/dl; p < .001), low-density lipoprotein (LDL) cholesterol (236 vs 324 mg/dl, p < .001), and LDL apoprotein B levels (186 vs 231 mg/dl; p < .001); and higher serum high-density lipoprotein (HDL) (46 vs 38 mg/dl; p < .05) and HDL2 cholesterol levels (25 vs 16 mg/dl; p < .05). However, most ileal bypass patients were still hypercholesterolemic, and their LDL cholesterol levels, and even more so their LDL apoprotein B levels, were still elevated, indicating that over the long term ileal bypass could not normalize plasma lipid levels in patients with heterozygous familial hypercholesterolemia and that a combination of surgery with hypolipidemic drugs may be needed.
FAMILIAL hypercholesterolemia is characterized by a marked elevation of plasma low-density lipoprotein (LDL) level due to impaired receptor-mediated catabolism of this lipoprotein by peripheral tissues.' This high LDL level seems to enhance development of coronary atheromatosis,' and the risk of myocardial infarction and coronary death is increased more than 10-fold in subjects under 60 years of age.2 Nine of 10 patients with this disorder die of coronary heart disease compared with three of 10 in the general population. 3 Thus, the mean life span of patients with heterozygous familial hypercholesterolemia is about 10 years shorter than that of the general population.3 Patients genetical-ly homozygous for familial hypercholesterolemia usually die before reaching sexual maturity.
It has been suggested that effective reduction of the LDL level would protect these patients from coronary atheromatosis and the clinical manifestations of coronary heart disease. Diet alone lowers the circulating cholesterol level inadequately in most cases. The bile acid-binding resins cholestyramine and colestipol are effective and in combination with nicotinic acid or neomycin frequently even normalize serum cholesterol in patients with heterozygous familial hypercholesterolemia, >6 The resins seem to correct, at least partly, the basic metabolic defect by promoting receptor-mediated catabolism of LDL.7 However, the partial ileal bypass operation8 9 is superior to cholestyramine in decreasing serum cholesterol in patients with heterozygous familial hypercholesterolemia.'0 After this procedure bypass of the distal third of the small bowel results, as during use of resins, in enhanced loss of cholesterol mainly as fecal bile acids." The decrease in serum cholesterol is due to a decrease in LDL choles-terol via increased receptor-mediated LDL catabo-lisml2 without change'3 or with an increase in HDL cholesterol. 4' 1 ' The present case-control study reports results of a 10 year follow-up in patients with heterozygous familial hypercholesterolemia who were either treated with ileal bypass or initially with hypolipidemic drugs.
Methods
Patients and design of the study. In the period from 1966 to 1976, 257 patients with apparent familial hypercholesterolemia were referred to the lipid clinic of our hospital for examination and treatment. 16 The diagnostic criteria for heterozygous familial hypercholesterolemia were hypercholesterolemia (>370 mg/ dl) with normal or modestly elevated serum triglyceride levels and tendon xanthomas and hypercholesterolemia or tendon xanthomas in at least one first-degree relative. Patients with findings typical for homozygous familial hypercholesterole-mial7 were excluded. At the first lipid clinic visit careful clinical and laboratory examinations were performed. Those who had been on hypolipidemic drugs before the first visit had discontinued their use for at least 1 month before the laboratory studies. After the baseline examinations patients participated in dietary and hypolipidemic drug trials to determine the optimal treatment schedule.
After initial examinations the partial ileal bypass operation9 was performed on 27 (17 men, 10 women) of these patients. '6 The remainder of the patients were prescribed a diet and hypolipidemic drugs. For the purpose of the present study a case control was selected for each ileal bypass patient from the remaining heterozygous familial hypercholesterolemia patients, with the use of predetermined criteria to form pairs as identical as possible with regard to existing coronary heart disease and its risk factors. The matching, performed on the basis of the data obtained during the first lipid clinic visit by a person not knowing the late outcome in the bypass patients or the case-control candidates, included the following criteria: (1) sex, (2) age + 3 years, (3) previous myocardial infarction, (4) angina pectoris, (5) ischemic type ST depression >0.5 mm and/or chest pain during the exercise electrocardiographic test, (6) blood pressure, (7) entry date (follow-up time), (8) presence of diabetes mellitus, (9) smoking habits, (10) relative body weight,'8 and (11) serum cholesterol concentration.
The first lipid clinic visit (in the period 1966 to 1976) was defined as the point of entry into the study. After entry the patients were asked to visit the lipid clinic at 3 to 12 month intervals, when lipid levels were measured. The final reexaminations were performed in November 1979 through February 1980 (the end of the study period). At the end of the follow-up five of the surgically treated patients were on hypolipidemic drug treatment with cholestyramine (6 to 16 g/day), mainly to control diarrhea. fl-Blocking agents were used by five ileal bypass patients. Ten of the control patients had continued using lipid-lowering agents. Two of them used nicotinic acid (1.0 to 1.5 g/day), five clofibrate (1.5 to 2.0 g/day), two cholestyramine (12 g/day), and one cholestyramine plus neomycin (1.5 g/ day). Five control patients were on fl-blocking agents and one woman reported taking aspirin regularly.
Laboratory measurements. Fasting serum total cholesterol'9 and triglyceride levels20 were determined with an AutoAnalyzer. For lipoprotein cholesterol measurement an enzymatic method was used.2' Very low-density lipoprotein (VLDL) was separated by ultracentrifugation at density less than 1.006. LDL and high-density lipoprotein (HDL) cholesterol and triglyceride levels were measured from the infranatant by the heparin-man-Vol. 70, No. 2, August 1984 ganese method.22 HDL2 and HDL3, determined in 10 bypass and 12 control subjects, were separated by ultracentrifugation (density classes 1.063 to 1. 125 and 1. 125 to 1.210, respectively). Apoprotein B concentration was determined from the infranatant after VLDL separation by immunodiffusion with commercial kits (M-Partigen; Behringwerke AG, Marburg, W. Germany).
Evaluation of coronary heart disease. A 12-channel resting electrocardiogram was obtained from all and an exercise electrocardiogram from all but seven of the patients during the first lipid clinic visit. For the exercise electrocardiogram the bicycle ergometer workload was increased stepwise by 40 to 50 W at 4 to 6 min intervals until 85% of the age-adjusted heart rate was reached, heart rate or blood pressure started to decrease, the patient complained of chest pain, or multiple ventricular premature beats appeared on the electrocardiogram. The final workload (W) and the total work (kJ) (sum of the products of workload and exercise time at each level) were determined. The appearance of a horizontal or down-sloping ST depression of more than 0.5 mm was considered to indicate ischemia.
The diagnosis of angina pectoris was based on typical history of anginal chest pain on effort that was relieved by rest or nitroglycerin. Myocardial infarction was verified by typical chest pain, increased enzyme concentrations and electrocardiographic changes, or by the appearance of a Q wave on the electrocardiogram during the follow-up. The cause of death was verified from the autopsy and hospital records and death certificates. Coronary death and nonfatal myocardial infarction were considered as actual new coronary events.
Statistics. The results are expressed as mean + SD. In comparing means the t test was used. The paired t test was used for paired observations of lhe same patient and for the comparison of the entry data from the surgically treated patients and from their case controls. However, owing to many discordant deaths (only one member of the pair died) the paired t test was not used for the comparison of the final values in the survivors. In discrete observations chi-square test with Yates correction was used. Linear correlations were calculated by the least squares method.
Results
The study groups at entry. The data in table 1 show that the matching of the two groups at entry was adequate. Serum triglycerides, which were not included in the matching, were slightly higher in the ileal bypass than in the control group. Only a quarter of the patients in each group was free from manifest coronary heart disease at entry. A quarter had had a myocardial infarction that had occurred at least 6 months before entry to the study. The remaining half suffered from angina pectoris.
New coronary events. During the 10 year follow-up eight surgically treated patients and seven control patients experienced a new coronary event. All but one of these (a male bypass patient) had had manifest coronary heart disease at the entry. Life-table analysis (data not shown) showed that the probability of the development of new coronary events increased linearly, the 10 year incidence being 30% in both groups. Events occurred concordantly in three matched pairs (two pairs died, one had myocardial infarction). Four male con- 1 0
Coronary heart disease (n) 21 19 Myocardial infarction (n) 7 6
Angina pectoris (n) 19 18
Exercise ECG (n) 26 21 Chest pain 9 (35%) 6 (29%) ST depression 13 (50%) 8 trol patients suffered coronary deaths (three myocardial infarctions and one sudden death) as did five men (three myocardial infarctions and two sudden deaths) in the bypass group. At entry all the patients who died in the follow-up period had angina pectoris and each of six had an old myocardial infarction. Three patients in each group (five men and one control woman) had nonfatal myocardial infarctions during the follow-up period. An additional male control subject died of carcinoma of the stomach. A three-vessel coronary artery bypass operation was performed in one man in the bypass group because of worsening angina pectoris. Three additional patients developed and three patients were relieved of angina in each group. The exercise electrocardiograms of the survivors were not significantly different with respect to final workload, total work, maximal heart rate, or appearance or disappearance of ischemic ST depression in the two groups.
With the exception of the initial serum triglyceride levels of those in the surgically treated group the initial risk factors for coronary heart disease shown in table 1 could not quite significantly predict new coronary events when the two groups were considered separately. However, when the groups were combined, male sex, smoking, high serum triglycerides, and angina were significant predictors of new coronary events (table 2).
Serum lipids in patients with new coronary events. The changes in serum cholesterol and triglyceride levels 292 before coronary events were compared with the simultaneous changes in those who had no new coronary events (table 3) . The serum cholesterol values at the time of events were lower in the surgically treated subjects without events than in the control subjects without events (p < .001). However, in the patients with new events the bypass procedure had decreased serum cholesterol relatively little and the preevent values were only insignificantly lower than in these patients in the control group. Figure 1 shows that in the surgically treated group the fall in serum cholesterol was significantly (p < .05) smaller during the first postoperative year in the patients who died (-18%) than in those who survived ( -36%). A similar trend was also seen in the conservatively treated control subjects ( figure 1 ).
In the group of patients who underwent bypass the initial triglyceride levels were significantly higher in the subjects experiencing new coronary events than in those that did not have an event. Before the events triglyceride levels were no more different between these patient groups, although the responses to the operation were not significant (table 3). In the controls initial triglyceride levels were not associated with the new coronary events and the serum levels were in- (table 4) . During the study the total serum cholesterol levels of the survivors had decreased in both groups, but the decrement was larger (-33% vs -1 %) and the final level was 23% lower in the ileal bypass than the control patients. However, the mean cholesterol level (360 mg/dl) was still markedly elevated and only two surgically treated patients were normocholesterolemic. The cholestyramine treatment used to control diarrhea in five surgically treated patients induced an inconsistent additional effect on serum cholesterol. In the control subjects the hypolipidemic drugs lowered the cholesterol level significantly (-17%; p < .05), while diet alone had no consistent influence (-6%). The mean initial and final serum triglyceride levels were similar in the two groups, but the 10 year increase was significant in the control subjects only. Lipoprotein analysis was performed at the end of the follow-up (table 4). The VLDL and HDL3 cholesterol levels were similar in the two groups, whereas the LDL cholesterol concentration was 27% lower and the total HDL and HDL, cholesterol contents significantly higher in the bypass group. Although LDL apoprotein B concentration was also lower in the bypass than in the control patients, the ratio of LDL cholesterol to LDL apoprotein B was higher in the control group. LDL was the only lipoprotein in which triglycerides were significantly decreased by the bypass procedure. A negative correlation was found between HDL and VLDL cholesterol in the surgically treated (r = -.554, p < .01), control (r = -.478, p < .05), and the total (bypass plus control) groups (figure 2). There was also a negative correlation between total triglyceride and HDL cholesterol levels in the bypass patients (r -.513, p < .05) and the total (bypass plus control) group (r = .419, p < .01), whereas in the control patients this correlation (r -.379, p > .05) did not quite reach statistical significance. EIn mg/g. ence in the response was due to the lesser effect of and poor adherence to the conservative treatment prescribed at the entry; in this study half of the case controls had discontinued their lipid clinic visits and drug regimens. The result was that an over 20% initial decrease in serum cholesterol level in these patients was reduced to a 11% decrease at 10 years, while in the bypass patients the respective figures were 36% and 33%. The falls in total serum and LDL cholesterol levels were similar to those reported earlier in familial hypercholesterolemia patients and those with other milder hyperlipidemias after a shorter follow-up. 10 121 14, 15. 3. 24 VLDL remained unchanged, whereas the bypass patients had higher HDL and HDL, cholesterol levels than the conservatively treated control patients. After a short follow-up ileal bypass has been reported to increase'4 or to have no effect24 on HDL in familial hypercholesterolemia patients. In patients with previous myocardial infarction ileal bypass also seems to increase HDL cholesterol level but apparently this oc-curs only in those with normal lipoprotein patterns.'5 Jejunoileal bypass performed for treatment of morbid obesity lowers HDL cholesterol level for a short time after the operation, but increased levels have been recorded after a longer follow-up. 25 The LDL cholesterol/apoprotein B ratio was smaller in the bypass patients than the controls, indicating that ileal bypass had reduced LDL cholesterol more than LDL apoprotein B level. The ratio LDL triglycerides/ LDL cholesterol or LDL apoprotein B was not consistently higher in the surgically treated than in the control subjects, suggesting that the operation had not increased levels of intermediate-density lipoproteins. An enrichment of apoprotein B in LDL has also been noted during cholestyramine treatment26 and in morbidly obese patients after jejunoileal bypass.> Adverse effects and tolerance. Operative mortality, which is usually very low (1% or less"3), was zero in our patients. The most important adverse effects of the ileal bypass operation are diarrhea and malabsorption of vitamin B2.23 Although half of our patients had frequent bouts with diarrhea during the 10 year followup, none of them required restoration of bowel continuity. In two patients diarrhea was frequently severe but was satisfactorily controlled by cholestyramine. 16 A somewhat lowered Schilling test result was found in two-thirds of the patients but, despite the fact that they were not on vitamin B,2 substitution therapy, only one had a low vitamin B,2 level in serum, indicating that vitamin B,2 deficiency develops very slowly. Despite slight fat malabsorption`6 our patients did not lose weight but, in contrast to the control patients, did not gain weight either (table 4 ). The incidence of other potential side effects, viz biliary and renal stones, .A A known to be increased in ileal dysfunction,27 28 tended to be higher in our ileal bypass than the control patients,16 but the differences were not statistically significant. Thus, the ileal bypass operation appears to be a safe procedure that is well tolerated by most of the patients and that induces a permanent, although not always satisfactory, reduction in LDL and total cholesterol levels in familial hypercholesterolemia patients. Outcome. Despite markedly different decreases in serum cholesterol and the increase in HDL, cholesterol after ileal bypass, the 10 year incidences of new coronary events were similar in the surgically treated and conservatively treated groups.
The 10 year incidence of the new major coronary events was 45% in all the men in the two groups. The respective figure for the women was only 5%. The incidence is quite high for men at this age even when manifest coronary heart disease at entry is considered. In other studies of patients with familial hypercholesterolemia of a similar age,2 29 the corresponding incidence is only one-third to one-half of that in our study group, but those series appear to include fewer subjects with symptomatic coronary disease. The low incidence of coronary events in our female patients with familial hypercholesterolemia has also been observed in other series.2 In addition to male sex, smoking, symptomatic coronary heart disease, and triglyceride levels at entry were significant predictors of new coronary events during our 10 year follow-up. The good prognosis for the women may be partly explained by the somewhat more frequent occurrence of these risk factors in the men than in the women in our study and also by the relatively high HDL levels in the women (figure 2).
The preventive role of ileal bypass has not yet been explored even in patients with the milder forms of hyperlipidemia, although an ongoing large controlled study will show if the procedure has preventive value in patients with previous myocardial infarction. 13 Even in view of the quite high incidence of coronary heart disease in patients with familial hypercholesterolemia, the effectiveness of ileal bypass in reducing cholesterol level, and the relatively long follow-up, the number of patients is too small in the present case-control study to allow for a definitive assessment of the preventive value of this operation in patients with familial hypercholesterolemia. It should also be noted that the decrease in serum cholesterol level obtained may still have been too small, particularly in familial hypercholesterolemia patients with symptomatic coronary heart disease at the entry. In fact, almost all the survivors in our study were still hypercholesterolemic, virtually all had elevated LDL cholesterol levels, and in the subjects who had coronary events the fall in serum cholesterol level appeared to be less than that in the survivors both in the control and surgically treated groups. Our findings suggest that the long-term lipid lowering induced by ileal bypass is not sufficient in all familial hypercholesterolemia patients and that some may need combination therapy with some drug. Bile acid-binding resin, for instance, caused a further decrease in serum cholesterol in the familial hypercholesterolemia patients who underwent bypass.30 Other drugs, e.g., neomycin, nicotinic acid, and probucol are also worth testing. Inhibition of cholesterol synthesis by mevinolin-type drug3' would be ideal.
Secondary prevention with only modest lipid lowering by drugs appears unsuccessful in men with previous myocardial infarction,32 while effective hypolipidemic drug treatment has been reported to reduce mortality and incidence of reinfarction in hyperlipidemic coronary patients. 33' 4 Other studies have indicated that regression of atheromatosis or at least the prevention of progression may be possible with effective lipid lowering.35
Recent primary prevention studies clearly demonstrated that cholesterol lowering by cholestyramine decreases the risk for coronary heart disease36 and that the decrease in the risk is proportional to the decrease in the cholesterol level. 37 The ileal bypass procedure and ion-binding resins work by essentially the same mechanism, but the ileal exclusion is clearly more potent in permanently lowering LDL cholesterol level and, in addition, increases HDL2 cholesterol. Since patients with familial hypercholesterolemia often develop coronary heart disease, a long-term effective lowering of LDL cholesterol level is indicated before clinical manifestations of coronary disease appear. A life-long adherence to drug treatment is unlikely, as shown by the present 10 year results. Therefore, serious consideration should be given to performing ileal bypass more frequently as a primary prevention measure in heterozygous patients with familial hypercholesterolemia.
